“Surgery remains the mainstay of treatment for early-stage [non-small cell lung cancer (NSCLC)], regardless of age,” researchers wrote in the Journal of Th oracic Oncology. “Although there are no formal practice guidelines for...
Read More
Variations in certain genes, including XRCC1, CYP1A1, CYP1A2, SEMA3B, PADPRP, and mEPHX, impact lung cancer outcomes in Hispanic/Latino patients.
Read More
In early NSCLC, researchers found a stepwise decline in 5-year survival as income quartile declined, implicating income as a predictor of mortality.
Read More
A new systemic nutrition-inflammation index predicted perioperative non-small cell lung cancer outcomes better than current nutrition and inflammation markers.
Read More
Hardeep Phull, MD, shares five key lessons for clinician career journeys, focusing on the necessity of risk-taking, failure, and reinvention.
Read More
